Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Rheumatology|August 3, 2015
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug TherapyMark C Genovese, Elizabeth Hsia, Stanley M Belkowski, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Identification of a potent and selective noncovalent cathepsin S inhibitorRobin L Thurmond, Siquan Sun, Clark A Sehon, et al.
Pharmacological Research|January 9, 2018
Histamine H<sub>4</sub> receptor antagonism prevents the progression of diabetic nephropathy in male DBA2/J miceAlessandro Pini, Cristina Grange, Eleonora Veglia, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitorsDarin J Gustin, Clark A Sehon, Jianmei Wei, et al.
The Journal of Dermatology|December 11, 2014
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitisYoko Murata, Michael Song, Hisayuki Kikuchi, et al.
Molecular Pharmacology|January 28, 2010
Molecular determinants of ligand binding to H4R species variantsHerman D Lim, Chris de Graaf, Wen Jiang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 28, 2013
Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivoJeffery M Cowden, Fuqu Yu, Mamatha Challapalli, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2006
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligandsAlice Lee-Dutra, Kristen L Arienti, Daniel J Buzard, et al.
European Journal of Immunology|September 5, 2013
Histamine synthesis is required for granule maturation in murine mast cellsShunsuke Nakazawa, Mariko Sakanaka, Kazuyuki Furuta, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2004
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancyShlomo Nedvetzki, Erez Gonen, Nathalie Assayag, et al.
Pageof 8